Editor's Note Researchers at Karolinska Institute in Sweden have developed artificial intelligence (AI) models that outperform human experts in detecting ovarian cancer using ultrasound images. As reported January 7 in DotMed, the AI was trained on over 17,000 images from 3,652 patients across 20 hospitals in eight countries, achieving an…

Read More

Editor's Note A new international study reports low rates of local recurrence, radionecrosis, and leptomeningeal disease in patients receiving neoadjuvant stereotactic radiosurgery (SRS) before brain metastases resection, Medscape Medical News reported January 6. Published in Radiotherapy and Oncology, the analysis included 179 patients with 189 brain metastases treated at nine…

Read More

Editor's Note A significant increase in the use of neoadjuvant systemic cancer therapies is among the most notable findings from the first annual cancer report from The American College of Surgeons (ACS) National Cancer Database (NCDB). The report also emphasizes the value of early detection, innovative therapies, and robust datasets…

Read More

Editor's Note Active monitoring for certain breast cancer patients offers similar outcomes to surgery with fewer side effects, according to research detailed in a December 16 article from Oncology News Central. Presented at the 2024 San Antonio Breast Cancer Symposium and published in JAMA, The COMET trial supports the safety…

Read More

Editor's Note Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative early breast cancer provides noninferior outcomes compared to undergoing the procedure, MedPage Today reported December 13. Presented at the San Antonio Breast Cancer Symposium and published in the New England Journal of Medicine, the INSEMA trial found…

Read More

Editor's Note Perioperative immunotherapy is reshaping treatment strategies for early-stage non-small cell lung cancer (NSCLC) without actionable mutations, according to Dr. Roy S. Herbst of Yale Cancer Center. In a recent interview with OncLive, the oncology expert highlighted the promise of neoadjuvant and adjuvant therapies to improve outcomes for these…

Read More

Editor's Note A scoping review of 15 studies reveals that the COVID-19 pandemic significantly disrupted oncological abdominal surgery (OAS), leading to postponed or canceled procedures, adoption of alternative treatment plans, and increased psychological stress among surgical teams. Published November 5 in the American Journal of Surgery, the findings emphasize the…

Read More

Editor's Note Stool-based testing strategies could significantly reduce the number of colonoscopies required for post-polypectomy colorectal cancer (CRC) surveillance while maintaining equivalent long-term outcomes in cancer incidence and mortality, according to research published August 30 in Gastroenterology. Conducted in the Netherlands, the cross-sectional observational study compared three stool tests—multitarget stool…

Read More

Editor's Note In a recent study, lung cancer patients using wearable devices showed significantly improved postoperative physical activity and pulmonary function as well as reduced symptoms such as dyspnea and pain. Published September 20 in Jama Network Open, the study compared 74 patients in the intervention group (who used wearable…

Read More

Editor's Note An algorithm developed by researchers at Duke University Medical Centre is designed to assist patients diagnosed with intermediate-stage liver cancer in making decisions about surgery, according to an October 9 report in News Medical Life Sciences. Known as the Modified Metroticket, this tool predicts overall survival and recurrence-free…

Read More